Uroliths composed of antiviral compound GS‐441524 in 2 cats undergoing treatment for feline infectious peritonitis

Uroliths composed of antiviral compound GS‐441524 in 2 cats undergoing treatment for feline infectious peritonitis

Abstract Feline infectious peritonitis (FIP) historically has been a fatal disease in cats. Recent unlicensed use of antiviral medication has been shown to markedly improve survival of this infection. An 8‐month‐old female spayed domestic short‐haired cat undergoing treatment for presumptive FIP wit...

Full description

Bibliographic Details
Main Authors:	Marissa Allinder, Beth Tynan, Cara Martin, Amelia Furbish, Glenn Austin, Joe Bartges, Bianca N. Lourenço
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Journal of Veterinary Internal Medicine
Subjects:	antivirals coronavirus feline fip GS‐441524 urolith
Online Access:	https://doi.org/10.1111/jvim.16954

Similar Items

Assessing in vitro stability of remdesivir (GS-5734) and conversion to GS-441524 in feline plasma and whole blood
by: Sally J. Coggins, et al.
Published: (2024-12-01)

Quantification of GS-441524 concentration in feline plasma using high performance liquid chromatography with fluorescence detection
by: Benjamin Kimble, et al.
Published: (2023-12-01)

Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis
by: Sarah Jones, et al.
Published: (2021-07-01)

Effect of GS-441524 in combination with the 3C-like protease inhibitor GC376 on the treatment of naturally transmitted feline infectious peritonitis
by: Jinbao Lv, et al.
Published: (2022-10-01)

Potential therapeutic effects of GS-441524 and GC376 in cats with feline infectious peritonitis
by: Omid Nekouei, et al.
Published: (2022-02-01)

Stopping Feline Coronavirus Shedding Prevented Feline Infectious Peritonitis
by: Diane D. Addie, et al.
Published: (2023-03-01)

Comparative Evaluation of GS-441524, Teriflunomide, Ruxolitinib, Molnupiravir, Ritonavir, and Nirmatrelvir for In Vitro Antiviral Activity against Feline Infectious Peritonitis Virus
by: Subarna Barua, et al.
Published: (2023-08-01)

Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS-441524 in pregnant rats
by: Ling Yang, et al.
Published: (2022-07-01)

Transplacental transfer of Remdesivir and GS‐441524: An ex vivo perfusion study
by: Margaux Louchet, et al.
Published: (2023-07-01)

Thirty‐two cats with effusive or non‐effusive feline infectious peritonitis treated with a combination of remdesivir and GS‐441524
by: Jodie Green, et al.
Published: (2023-09-01)

Coronavirus Infection of the Central Nervous System: Animal Models in the Time of COVID-19
by: Peter J. Dickinson
Published: (2020-10-01)

Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524
by: Daniela Krentz, et al.
Published: (2021-11-01)

Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐19
by: Henrik Berg Rasmussen, et al.
Published: (2022-04-01)

Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19
by: Henrik Berg Rasmussen, et al.
Published: (2021-07-01)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
by: Shiho Chiba, et al.
Published: (2022-02-01)

Relative supersaturation values distinguish between feline urinary and non-urinary foods and align with expected urine analytes contributions to uroliths
by: Elizabeth M. Morris, et al.
Published: (2023-08-01)

Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
by: Linda Brunotte, et al.
Published: (2021-09-01)

Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase
by: Zhonglei Wang, et al.
Published: (2022-12-01)

Clinical Follow-Up and Postmortem Findings in a Cat That Was Cured of Feline Infectious Peritonitis with an Oral Antiviral Drug Containing GS-441524
by: Daniela Krentz, et al.
Published: (2022-09-01)

Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment
by: Amy Q. Wang, et al.
Published: (2022-08-01)

Retrospective analysis of 131 feline uroliths from the Republic of Ireland and Northern Ireland (2010-2020)
by: Cristina J. Ortega, et al.
Published: (2023-02-01)

Peritonite infecciosa felina: Revisão
by: Isabela Lopes Massitel, et al.
Published: (2021-01-01)

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
by: Rana Abdelnabi, et al.
Published: (2022-12-01)

Fecal Feline Coronavirus RNA Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524
by: Marina L. Meli, et al.
Published: (2022-05-01)

Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
by: Meagan Roy, et al.
Published: (2022-10-01)

Successful Treatment of Urolith in a Neutered Persian Cat: A Case Report
by: Ahmad Asadi Ardebili, et al.
Published: (2023-03-01)

A large urolith in an eight year-old mare: a case report
by: R. Kozdrowski, et al.
Published: (2010-06-01)

<i>In Vitro</i> Effects of Doxycycline on Replication of Feline Coronavirus
by: Magdalena Dunowska, et al.
Published: (2021-03-01)

Treatment of Three Ferrets Diagnosed with Ferret Systemic Coronaviral Disease Using the Nucleoside Analogue GS-441524
by: Julia Puffal, et al.
Published: (2024-03-01)

Risk factors for progression of Urolith Associated with Obstructive Urosepsis to severe sepsis or septic shock
by: J. D. Cao, et al.
Published: (2022-03-01)

Concordance between Histology, Immunohistochemistry, and RT-PCR in the Diagnosis of Feline Infectious Peritonitis
by: Angelica Stranieri, et al.
Published: (2020-10-01)

Risk factors for upper urinary tract uroliths and ureteral obstruction in cats under referral veterinary care in the United Kingdom
by: Rebecca F. Geddes, et al.
Published: (2023-03-01)

Intestinal injury and vasculitis biomarkers in cats with feline enteric coronavirus and effusive feline infectious peritonitis
by: Erdem Gülersoy, et al.
Published: (2023-11-01)

ERDRP-0519 inhibits feline coronavirus in vitro
by: Michele Camero, et al.
Published: (2022-01-01)

Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials
by: Brian G. Murphy, et al.
Published: (2024-03-01)

Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines
by: Séverine Tasker, et al.
Published: (2023-08-01)

Molecular Detection of Feline Coronavirus Based on Recombinase Polymerase Amplification Assay
by: Rea Maja Kobialka, et al.
Published: (2021-09-01)

Correlation of Feline Coronavirus Shedding in Feces with Coronavirus Antibody Titer
by: Sandra Felten, et al.
Published: (2020-07-01)

Sequence Analysis of Feline Coronaviruses and the Circulating Virulent/Avirulent Theory
by: Hui-Wen Chang, et al.
Published: (2011-04-01)

Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524
by: Sally J. Coggins, et al.
Published: (2023-09-01)